NCT00846911View on ClinicalTrials.gov

AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

CompletedOBSERVATIONAL

Enrollment

2,672

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Bronchitis, Chronic

Interventions

DRUG

Moxifloxacin (Avelox, BAY12-8039)

Patients with acute exacerbation of chronic bronchitis for whom the physician decided to prescribe moxifloxacin

Trial Locations (8)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT00846911 - AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs | Biotech Hunter | Biotech Hunter